GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » BMP Pharma Trading AG (STU:BMP) » Definitions » EV-to-Revenue

BMP Pharma Trading AG (STU:BMP) EV-to-Revenue : 15,813.00 (As of May. 31, 2025)


View and export this data going back to . Start your Free Trial

What is BMP Pharma Trading AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BMP Pharma Trading AG's enterprise value is €31.63 Mil. BMP Pharma Trading AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil. Therefore, BMP Pharma Trading AG's EV-to-Revenue for today is 15,813.00.

The historical rank and industry rank for BMP Pharma Trading AG's EV-to-Revenue or its related term are showing as below:

STU:BMP' s EV-to-Revenue Range Over the Past 10 Years
Min: 213.35   Med: 1008.79   Max: 9305.25
Current: 15813

During the past 13 years, the highest EV-to-Revenue of BMP Pharma Trading AG was 9305.25. The lowest was 213.35. And the median was 1008.79.

STU:BMP's EV-to-Revenue is ranked worse than
100% of 111 companies
in the Medical Distribution industry
Industry Median: 0.67 vs STU:BMP: 15813.00

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-31), BMP Pharma Trading AG's stock price is €6.00. BMP Pharma Trading AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00. Therefore, BMP Pharma Trading AG's PS Ratio for today is .


BMP Pharma Trading AG EV-to-Revenue Historical Data

The historical data trend for BMP Pharma Trading AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BMP Pharma Trading AG EV-to-Revenue Chart

BMP Pharma Trading AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,818.00 1,889.63 8,569.00 - 10,563.00

BMP Pharma Trading AG Semi-Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,569.00 - - - 10,563.00

Competitive Comparison of BMP Pharma Trading AG's EV-to-Revenue

For the Medical Distribution subindustry, BMP Pharma Trading AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BMP Pharma Trading AG's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BMP Pharma Trading AG's EV-to-Revenue falls into.


;
;

BMP Pharma Trading AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BMP Pharma Trading AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=31.626/0.002
=15,813.00

BMP Pharma Trading AG's current Enterprise Value is €31.63 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BMP Pharma Trading AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BMP Pharma Trading AG  (STU:BMP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BMP Pharma Trading AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.00/0
=

BMP Pharma Trading AG's share price for today is €6.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BMP Pharma Trading AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BMP Pharma Trading AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BMP Pharma Trading AG Business Description

Traded in Other Exchanges
N/A
Address
Bornbarch 16, Norderstedt, SH, DEU, 22848
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.

BMP Pharma Trading AG Headlines

No Headlines